Clinical Trial Update: Immunogenicity and Safety of A Lyophilized Purified Human Diploid Cell Rabies Vaccine . [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Lyophilized purified human diploid cell rabies vaccine

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Adverse Effect and Immunogenicity of Vaccine | Phase 3 | Status: COMPLETED